PORTON BIOPHARMA LIMITED

Company number 09331560

Date	Type	Description	View / Download
06 Apr 2020	CH01	Director's details changed for Roger James Hinton on 3 April 2020	(2 pages)
14 Feb 2020	AP01	Appointment of Ms Rebecca Wilson as a director on 11 February 2020	(2 pages)
23 Dec 2019	AA	Full accounts made up to 31 March 2019	(30 pages)
27 Nov 2019	CS01	Confirmation statement made on 27 November 2019 with updates	(4 pages)
14 Nov 2019	AP01	Appointment of Mr Donald Anthony Shepherd as a director on 12 November 2019	(2 pages)
01 Nov 2019	TM01	Termination of appointment of Martin Hindle as a director on 31 October 2019	(1 page)
02 Sep 2019	TM01	Termination of appointment of Michael Brodie as a director on 30 August 2019	(1 page)
29 Jul 2019	TM01	Termination of appointment of Nigel Stanley Brooksby as a director on 30 June 2019	(1 page)
27 Mar 2019	SH01	Statement of capital following an allotment of shares on 13 March 2019 GBP 67,976,000	(3 pages)
15 Feb 2019	TM01	Termination of appointment of Michael Harrison as a director on 15 February 2019	(1 page)
08 Jan 2019	AP01	Appointment of Mr Barry Clare as a director on 3 December 2018	(2 pages)
28 Nov 2018	CS01	Confirmation statement made on 27 November 2018 with updates	(4 pages)
22 Aug 2018	AA	Full accounts made up to 31 March 2018	(28 pages)
15 May 2018	SH01	Statement of capital following an allotment of shares on 16 March 2018 GBP 58,976,000	(3 pages)
10 Jan 2018	SH01	Statement of capital following an allotment of shares on 22 December 2017 GBP 53,576,000	(3 pages)
29 Dec 2017	AA	Full accounts made up to 31 March 2017	(30 pages)
19 Dec 2017	SH01	Statement of capital following an allotment of shares on 2 October 2017 GBP 51,884,000	(3 pages)
30 Nov 2017	CS01	Confirmation statement made on 27 November 2017 with updates	(4 pages)
16 May 2017	SH01	Statement of capital following an allotment of shares on 14 March 2017 GBP 46,384,000	(3 pages)
16 May 2017	AP01	Appointment of Mr Michael Harrison as a director on 8 May 2017	(2 pages)
31 Jan 2017	TM01	Termination of appointment of Patrick Mark Herbert Mills as a director on 31 January 2017	(1 page)
06 Dec 2016	CS01	Confirmation statement made on 27 November 2016 with updates	(5 pages)
05 Dec 2016	AA	Full accounts made up to 31 March 2016	(28 pages)
20 Oct 2016	SH01	Statement of capital following an allotment of shares on 1 September 2016 GBP 20,000,000	(3 pages)
09 Jun 2016	AP01	Appointment of Mr Nigel Stanley Brooksby as a director on 1 June 2016	(2 pages)